EMBL-EBI | Chemical Biology | ChEBI

Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search

CHEBI:32020 - pitavastatin

Default Structure
ChEBI IDCHEBI:32020
ChEBI Namepitavastatin
Stars
DefinitionA dihydroxy monocarboxylic acid that is (6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]hept-6-enoic acid in which the two hydroxy groups are located at positions 3 and 5 (the 3R,5S-stereoisomer). Used as its calcium salt for treatment of hypercholesterolemia (elevated levels of cholesterol in the blood) on patients unable to sufficiently lower their cholesterol levels by diet and exercise.
Last Modified22 February 2017
DownloadsMolfile
FormulaC25H24FNO4
Net Charge0
Average Mass421.468
Monoisotopic Mass421.16894
SMILESO=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1
InChIInChI=1S/C25H24FNO4/c26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31/h1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31)/b12-11+/t18-,19-/m1/s1
InChIKeyVGYFMXBACGZSIL-MCBHFWOFSA-N
Wikipedia
Roles Classification
Chemical Roles:
antioxidant  A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
Bronsted acid  A molecular entity capable of donating a hydron to an acceptor (Brønsted base).
Biological Roles:
antiviral agent  A substance that destroys or inhibits replication of viruses.
EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor  Any EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that inhibits HMG-CoA reductases. Hydroxymethylglutaryl-CoA reductase inhibitors have been shown to lower directly cholesterol synthesis. The Enzyme Commission designation is EC 1.1.1.34 for the NADPH-dependent enzyme and EC 1.1.1.88 for an NADH-dependent enzyme.
Applications:
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
hypoglycemic agent  A drug which lowers the blood glucose level.
cardiovascular drug  A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume.
anticholesteremic drug  A substance used to lower plasma cholesterol levels.
ChEBI Ontology
Outgoing Relation(s)
pitavastatin (CHEBI:32020) has role antineoplastic agent (CHEBI:35610)
pitavastatin (CHEBI:32020) has role antioxidant (CHEBI:22586)
pitavastatin (CHEBI:32020) has role antiviral agent (CHEBI:22587)
pitavastatin (CHEBI:32020) has role cardiovascular drug (CHEBI:35554)
pitavastatin (CHEBI:32020) has role hypoglycemic agent (CHEBI:35526)
pitavastatin (CHEBI:32020) is a cyclopropanes (CHEBI:51454)
pitavastatin (CHEBI:32020) is a dihydroxy monocarboxylic acid (CHEBI:35972)
pitavastatin (CHEBI:32020) is a monofluorobenzenes (CHEBI:83575)
pitavastatin (CHEBI:32020) is a quinolines (CHEBI:26513)
pitavastatin (CHEBI:32020) is a statin (synthetic) (CHEBI:87635)
pitavastatin (CHEBI:32020) is conjugate acid of pitavastatin(1−) (CHEBI:71260)
Incoming Relation(s)
pitavastatin(1−) (CHEBI:71260) is conjugate base of pitavastatin (CHEBI:32020)
IUPAC Name 
(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
INNs  Source
pitavastatiaWHO MedNet
pitavastatinWHO MedNet
pitavastatinaWHO MedNet
pitavastatineWHO MedNet
pitavastatinumWHO MedNet
Synonyms  Source
NK 104ChemIDplus
NK-104ChemIDplus
NSC-760423ChEMBL
Brand Name  Source
Pitavastatin component of k-924 pivastatinChEMBL
Manual XrefsDatabases
2214DrugCentral
C13334KEGG COMPOUND
EP2141155Patent
HMDB0041991HMDB
PitavastatinWikipedia
US2011269962Patent
US2012016129Patent
Registry NumbersSources
Reaxys:7257773Reaxys
CAS:147511-69-1ChemIDplus
Citations